{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-117745","form_type":"8-K","ticker":"EYPT","cik":"0001314102","company_name":"EyePoint, Inc.","filed_at":"2026-03-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.764496+00:00","generated_at":"2026-05-15T09:27:37.283834+00:00","sec_items":["7.01"],"event_type":"litigation","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"EyePoint files defamation lawsuit against Ocular Therapeutix over false statements about DURAVYU","bullets":["Complaint filed March 20, 2026 in Middlesex County Superior Court (Massachusetts).","Alleges Ocular Therapeutix made false/misleading representations about EyePoint's lead product DURAVYU (vorolanib intravitreal insert).","Claims include defamation, commercial disparagement, violation of Mass. Gen. L. c. 93A, and tortious interference.","Seeks injunctive relief, public retraction, monetary damages, attorneys' fees, and other relief.","EyePoint asserts defendant's actions harmed its business relations and clinical results reputation."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-117745","json":"https://secwatch.observer/filing/0001193125-26-117745.json","markdown":"https://secwatch.observer/filing/0001193125-26-117745.md","text":"https://secwatch.observer/filing/0001193125-26-117745.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1314102/000119312526117745/0001193125-26-117745-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1314102/000119312526117745/eypt-20260320.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T09:27:37.283834+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}